We are live on ! Find out more
TECX

Tectonic Therapeutic
TECX

45 hedge funds and large institutions have $14.8M invested in Tectonic Therapeutic in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.7% less ownership

Funds ownership: 4.65% → 3.96% (-0.7%)

5% less capital invested

Capital invested by funds: $15.7M → $14.8M (-$859K)

17% less funds holding

Funds holding: 54 → 45 (-9)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

Holders
45
Holders Change
-9
Holders Change %
-16.67%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
15
Closed
14
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
N
Natixis
France
+$645K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$211K
3
PFMU
Privium Fund Management (UK)
United Kingdom
+$113K
4
LPL Financial
LPL Financial
California
+$89.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$51.9K

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$1.76M
2
Goldman Sachs
Goldman Sachs
New York
-$511K
3
BlackRock
BlackRock
New York
-$354K
4
Renaissance Technologies
Renaissance Technologies
New York
-$264K
5
GC
GMT Capital
Georgia
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$3.22M – – –
GC
2
GMT Capital
Georgia
$2.36M -$135K -15,386 -5%
BlackRock
3
BlackRock
New York
$1.08M -$354K -40,269 -24%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$1.05M +$211K +24,011 +24%
Vanguard Group
5
Vanguard Group
Pennsylvania
$826K +$686 +78 +0.1%
ACM
6
Aisling Capital Management
New York
$717K – – –
N
7
Natixis
France
$627K +$645K +73,333 New
Renaissance Technologies
8
Renaissance Technologies
New York
$615K -$264K -29,989 -29%
FCM
9
Farallon Capital Management
California
$528K – – –
Millennium Management
10
Millennium Management
New York
$491K -$15.3K -1,738 -3%
MB
11
MPM BioImpact
Massachusetts
$462K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$416K +$51.9K +5,899 +14%
Morgan Stanley
13
Morgan Stanley
New York
$387K +$23.3K +2,643 +6%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$275K -$686 -78 -0.2%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$244K -$37K -4,200 -13%
Two Sigma Investments
16
Two Sigma Investments
New York
$227K -$54.8K -6,231 -19%
NLVP
17
New Leaf Venture Partners
New York
$225K – – –
SW
18
SVB Wealth
Massachusetts
$203K – – –
PFMU
19
Privium Fund Management (UK)
United Kingdom
$188K +$113K +12,809 +140%
BCM
20
Bridgeway Capital Management
Texas
$111K – – –
State Street
21
State Street
Massachusetts
$100K – – –
LPL Financial
22
LPL Financial
California
$87.4K +$89.9K +10,215 New
Wells Fargo
23
Wells Fargo
California
$63.8K -$4.07K -462 -6%
Northern Trust
24
Northern Trust
Illinois
$52.7K – – –
E
25
Ergoteles
New York
$33.4K -$46.1K -5,237 -57%
1
2 3

TECX Hedge Fund Activity: Q4 2022 in Review

45 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2022, worth a combined $14.8M — down 5.5% from $15.7M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TECX and 5 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 8 added.

The largest buyer was Natixis, opening a new position worth an estimated $645K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $1.76M sold.

  • 45 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2022, down from 54 in Q3 2022.
  • Funds reported $14.8M of Tectonic Therapeutic stock for Q4 2022, down 5.5% quarter-over-quarter.
  • 5 funds opened new Tectonic Therapeutic positions in Q4 2022 and 14 closed out, a net change of -9 holders.
  • The largest Tectonic Therapeutic buyer in Q4 2022 was Natixis, an estimated $645K added.
  • The largest Tectonic Therapeutic seller in Q4 2022 was K2 Principal Fund, an estimated $1.76M sold.

Based on aggregated 13F filings for Q4 2022.